SPECT used to investigate therapy to slow Alzheimer's progression

01/1/2009 | Ridgefield Press (Conn.), The

The ICARA study is using SPECT scans to investigate the efficacy of an intravenous medication called Bapineuzumab in slowing down the progression of late-stage Alzheimer's disease. The treatment also has antibody proteins that help to clear amyloid within the plaque in the brain.

View Full Article in:

Ridgefield Press (Conn.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT